Today: 9 June 2026
HSBC share price slips from record highs as investors weigh Fed pause and Hang Seng move
29 January 2026
1 min read

HSBC share price slips from record highs as investors weigh Fed pause and Hang Seng move

London, Jan 29, 2026, 07:57 GMT — Premarket

HSBC’s London-listed shares (HSBA) slipped 1.46% on Wednesday, finishing at 1,258.6 pence. The drop trimmed some of this week’s recent gains but kept the stock close to its year-to-date peak ahead of Thursday’s session.

The pullback is significant since HSBC has led a surge in UK banks, making it one of the biggest contributors to the FTSE 100’s gains. On Tuesday, shares climbed to a record 12.77 pounds, briefly lifting the bank’s market cap past $300 billion. That move put HSBC almost level with AstraZeneca for the highest valuation on the blue-chip index.

Rate bets underpin that trade. Net interest income—the difference between what banks earn on loans and pay out on deposits—can shift rapidly as markets adjust expectations for policy rates.

Broader UK stocks slipped on Wednesday, with investors shifting their focus to U.S. tech shares while adopting a cautious stance ahead of upcoming policy announcements and earnings reports. “There seems to have been a rotation out of European and U.K. stocks in favour of U.S. technology stocks,” said Axel Rudolph, senior financial analyst at IG. Reuters

The U.S. Federal Reserve kept its benchmark interest rate steady overnight at 3.50%-3.75%. Fed Chair Jerome Powell noted the economy had “once again surprised us with its strength.” Meanwhile, Michael Pearce, chief U.S. economist at Oxford Economics, said he anticipates the Fed will maintain an “extended pause.” Reuters

HSBC and its peers face a slower march toward rate cuts, which helps lending margins hold up. But that also means funding costs stay elevated, prompting investors to pull back from bank stocks faster if growth numbers weaken.

Company news injected fresh movement. HSBC confirmed its privatisation of Hang Seng Bank took effect on Jan. 26, with the subsidiary’s shares pulled from the Hong Kong market on Jan. 27. Investors can expect cash payments by Feb. 4. “By bringing together our shared heritage, Hang Seng Bank’s local strength and HSBC’s global reach, we will help ideas travel further,” said group CEO Georges Elhedery. HSBC

In a separate filing, HSBC revealed it increased its voting stake in International Personal Finance to 7.152% from 6.130% following a recent purchase.

The rally has tightened the margin for error. Signs of slowing revenue growth, a jump in credit losses, or even a more conservative stance on expenses might trigger a sharper sell-off in the shares.

HSBC’s annual results on Feb. 25 will be the next key trigger, with investors eager for updated guidance on profitability and the bank’s outlook on interest rates.

Stock Market Today

  • Wheat Prices Mixed as Winter Wheat Gains on U.S. Crop Progress
    June 9, 2026, 9:22 AM EDT. Wheat markets closed mixed on Monday, with winter wheat futures rising across Chicago and Kansas City exchanges, while Minneapolis spring wheat fell slightly. The U.S. Department of Agriculture's Crop Progress report showed 92% of winter wheat heading, 7% ahead of average, and spring wheat planting at 98%, with improving crop conditions. Export inspections dropped 20.65% from last week but marketing year shipments rose 9.13% compared to last year. Ukraine's wheat crop estimate increased by 1.8 million tonnes to 21.7 million tonnes. Futures finished with Chicago SRW wheat up 1 to 3 ¼ cents and Kansas City HRW wheat up 2 ¼ to 9 cents, contrasting the modest decline in Minneapolis spring wheat.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus
Previous Story

Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus

Babcock share price today: BAB slips after fresh buyback filing, March year-end in focus
Next Story

Babcock share price today: BAB slips after fresh buyback filing, March year-end in focus

Go toTop